Dnyaneshwar Kalyane

3.3k total citations · 2 hit papers
20 papers, 1.9k citations indexed

About

Dnyaneshwar Kalyane is a scholar working on Biomedical Engineering, Biomaterials and Materials Chemistry. According to data from OpenAlex, Dnyaneshwar Kalyane has authored 20 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Biomedical Engineering, 9 papers in Biomaterials and 4 papers in Materials Chemistry. Recurrent topics in Dnyaneshwar Kalyane's work include Nanoplatforms for cancer theranostics (9 papers), Nanoparticle-Based Drug Delivery (7 papers) and Photodynamic Therapy Research Studies (3 papers). Dnyaneshwar Kalyane is often cited by papers focused on Nanoplatforms for cancer theranostics (9 papers), Nanoparticle-Based Drug Delivery (7 papers) and Photodynamic Therapy Research Studies (3 papers). Dnyaneshwar Kalyane collaborates with scholars based in India, South Africa and Saudi Arabia. Dnyaneshwar Kalyane's co-authors include Rakesh Kumar Tekade, Kiran Kalia, Nidhi Raval, Rahul Maheshwari, Vishakha Tambe, Suryanarayana Polaka, Kuldeep Rajpoot, Neelima Anup, Katharigatta N. Venugopala and Pinaki Sengupta and has published in prestigious journals such as Progress in Materials Science, International Journal of Pharmaceutics and Drug Discovery Today.

In The Last Decade

Dnyaneshwar Kalyane

20 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Artificial intelligence in drug discovery and development

2020 850 citations Dnyaneshwar Kalyane, Kiran Kalia et al. Drug Discovery Today profile →
Employment of enhanced permeability and retention effect (EPR): Nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer

2019 676 citations Dnyaneshwar Kalyane, Nidhi Raval et al. Materials Science and Engineering C profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dnyaneshwar Kalyane India	12	634	627	475	356	335	20	1.9k
Kit‐Kay Mak Malaysia	16	195 0.3×	413 0.7×	138 0.3×	312 0.9×	161 0.5×	43	1.3k
Huang Li China	30	1.1k 1.7×	1.7k 2.7×	222 0.5×	117 0.3×	1.2k 3.5×	96	3.9k
Hongxiang Hu United States	15	444 0.7×	703 1.1×	351 0.7×	267 0.8×	147 0.4×	36	1.9k
Liming Hu China	27	595 0.9×	667 1.1×	282 0.6×	43 0.1×	972 2.9×	93	2.9k
Rebeca García‐Fandiño Spain	24	202 0.3×	767 1.2×	411 0.9×	121 0.3×	181 0.5×	82	1.8k
Simon Zhou United States	22	391 0.6×	754 1.2×	296 0.6×	283 0.8×	145 0.4×	71	2.5k
Senyi Deng China	17	165 0.3×	424 0.7×	224 0.5×	103 0.3×	53 0.2×	48	1.1k
Alleyn T. Plowright Sweden	25	227 0.4×	1.4k 2.2×	78 0.2×	512 1.4×	255 0.8×	48	2.7k
Zhihui Wang United States	28	570 0.9×	581 0.9×	630 1.3×	35 0.1×	136 0.4×	109	2.2k

Countries citing papers authored by Dnyaneshwar Kalyane

Since Specialization

Citations

This map shows the geographic impact of Dnyaneshwar Kalyane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dnyaneshwar Kalyane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dnyaneshwar Kalyane more than expected).

Fields of papers citing papers by Dnyaneshwar Kalyane

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dnyaneshwar Kalyane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dnyaneshwar Kalyane. The network helps show where Dnyaneshwar Kalyane may publish in the future.

Co-authorship network of co-authors of Dnyaneshwar Kalyane

This figure shows the co-authorship network connecting the top 25 collaborators of Dnyaneshwar Kalyane. A scholar is included among the top collaborators of Dnyaneshwar Kalyane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dnyaneshwar Kalyane. Dnyaneshwar Kalyane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kalyane, Dnyaneshwar, et al.. (2025). Abstract A048: Targeting M2 macrophage polarization: The anti-tumor effects of IL-4/IL-13 blocking peptide (KROS-401) and iron oxide nanoparticles. Cancer Immunology Research. 13(2_Supplement). A048–A048. 1 indexed citations

Vasdev, Nupur, et al.. (2025). Harnessing Exercise-Like Benefits of Protonation prone Liposomal Resveratrol in Differentiated Fat Cells: A Proof-of-Concept Study. AAPS PharmSciTech. 26(4). 98–98. 2 indexed citations

Kalyane, Dnyaneshwar, et al.. (2024). Elucidation of processing parameters for the reverse engineering of tablets. 1(2). 333–343. 1 indexed citations

Choudhary, Manisha, et al.. (2023). Stimuli-Responsive Nanotherapeutics for Treatment and Diagnosis of Stroke. Pharmaceutics. 15(4). 1036–1036. 5 indexed citations

Tambe, Vishakha, Dnyaneshwar Kalyane, Neelima Anup, et al.. (2022). Nanomaterials assisted chemo-photothermal therapy for combating cancer drug resistance. Journal of Drug Delivery Science and Technology. 70. 103164–103164. 26 indexed citations

Kalyane, Dnyaneshwar, Suryanarayana Polaka, Nupur Vasdev, & Rakesh Kumar Tekade. (2022). CD44-Receptor Targeted Gold-Doxorubicin Nanocomposite for Pulsatile Chemo-Photothermal Therapy of Triple-Negative Breast Cancer Cells. Pharmaceutics. 14(12). 2734–2734. 11 indexed citations

Kalyane, Dnyaneshwar, Suryanarayana Polaka, Nupur Vasdev, & Rakesh Kumar Tekade. (2022). Cancer Cell‐Specific and Laser‐Activatable NanoSeeds for Targeted Photothermal Ablation of Triple‐Negative Breast Cancer. Photochemistry and Photobiology. 99(4). 1157–1171. 6 indexed citations

Kalyane, Dnyaneshwar, et al.. (2022). Reactive oxygen nano-generators for cancer therapy. Progress in Materials Science. 130. 100974–100974. 45 indexed citations

Anup, Neelima, Suryanarayana Polaka, Dnyaneshwar Kalyane, et al.. (2021). Reinforced electrospun nanofiber composites for drug delivery applications. Journal of Biomedical Materials Research Part A. 109(10). 2036–2064. 32 indexed citations

10.

Kalyane, Dnyaneshwar, Narendra Kumar, Neelima Anup, et al.. (2021). Recent advancements and future submissions of silica core-shell nanoparticles. International Journal of Pharmaceutics. 609. 121173–121173. 17 indexed citations

11.

Polaka, Suryanarayana, et al.. (2021). Integrated nanomaterials for non-invasive photothermal therapy of rheumatoid arthritis. Drug Discovery Today. 26(10). 2315–2328. 27 indexed citations

12.

Sreeharsha, Nagaraja, Kuldeep Rajpoot, Muktika Tekade, et al.. (2020). Development of Metronidazole Loaded Chitosan Nanoparticles Using QbD Approach—A Novel and Potential Antibacterial Formulation. Pharmaceutics. 12(10). 920–920. 38 indexed citations

13.

Kalyane, Dnyaneshwar, Suryanarayana Polaka, Neelima Anup, et al.. (2020). Exosomes in multidrug-resistant cancer. Current Opinion in Pharmacology. 54. 109–120. 5 indexed citations

14.

Raval, Nidhi, et al.. (2020). Understanding molecular upsets in diabetic nephropathy to identify novel targets and treatment opportunities. Drug Discovery Today. 25(5). 862–878. 39 indexed citations

15.

Raval, Nidhi, Dnyaneshwar Kalyane, Vishakha Tambe, et al.. (2020). Glucosamine-conjugated nanoseeds for chemo-magneto hyperthermia therapy of cancer. Journal of Drug Delivery Science and Technology. 61. 102295–102295. 10 indexed citations

16.

Raval, Nidhi, Dnyaneshwar Kalyane, Neelima Anup, et al.. (2020). NanoGold-core dendrimeric seeds for combined chemo-, photothermal-, and photodynamic therapy of cancer. Journal of Drug Delivery Science and Technology. 58. 101814–101814. 20 indexed citations

17.

Kalyane, Dnyaneshwar, et al.. (2020). Artificial intelligence in drug discovery and development. Drug Discovery Today. 26(1). 80–93. 850 indexed citations breakdown →

18.

Maheshwari, Rahul, et al.. (2020). Green Graphene Nanoplates for Combined Photo-Chemo-Thermal Therapy of Triple-Negative Breast Cancer. Nanomedicine. 15(6). 581–601. 34 indexed citations

19.

Kalyane, Dnyaneshwar, Nidhi Raval, Rahul Maheshwari, et al.. (2019). Employment of enhanced permeability and retention effect (EPR): Nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer. Materials Science and Engineering C. 98. 1252–1276. 676 indexed citations breakdown →

20.

Kalyane, Dnyaneshwar, et al.. (2019). Evolving nanoformulation strategies for diagnosis and clinical interventions for Parkinson’s disease. Drug Discovery Today. 25(2). 392–405. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact